Oliva, Alessandra http://orcid.org/0000-0003-0832-7975
Liguori, L
Covino, S
Petrucci, F
Cogliati-Dezza, F
Curtolo, A
Savelloni, G
Comi, M
Sacco, F
Ceccarelli, G
Viscido, A
Alessandri, F
Raponi, G
Pugliese, F
Mastroianni, CM
Venditti, M
Funding for this research was provided by:
Università degli Studi di Roma La Sapienza
Article History
Received: 8 September 2023
Accepted: 9 April 2024
First Online: 18 April 2024
Declarations
:
: OA participated to advisory boards or speaker’s bureau for MSD, Zambon and Angelini. VM participated to advisory boards or speaker’s bureau for Gilead, MSD and Mundipharma. MCM participated to advisory boards or speaker’s bureau for Gilead, ASTRA-Zeneca, GSK, and Angelini. Other authors declare no conflict of interest.
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the local Institutional Review Board.
: Specific informed consent was waived due to the retrospective nature of the research. Patients (or their representatives) provided consent for use of data for research purposes.
: Not applicable.